BE885966A - NEUROBIOTOPIC CAPSULES - Google Patents

NEUROBIOTOPIC CAPSULES Download PDF

Info

Publication number
BE885966A
BE885966A BE1/10006A BE1010006A BE885966A BE 885966 A BE885966 A BE 885966A BE 1/10006 A BE1/10006 A BE 1/10006A BE 1010006 A BE1010006 A BE 1010006A BE 885966 A BE885966 A BE 885966A
Authority
BE
Belgium
Prior art keywords
capsules
neurobiotopic
emi
neurobiotope
extractum
Prior art date
Application number
BE1/10006A
Other languages
Dutch (nl)
Original Assignee
Willaert Raphael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Willaert Raphael filed Critical Willaert Raphael
Priority to BE1/10006A priority Critical patent/BE885966A/en
Publication of BE885966A publication Critical patent/BE885966A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Description

       

  BESCHRIJVING

  
aanvrager : Raphael Willaert, apotheker, wonende te Westrozebeke, Ommegang Oost 7.

  
octrooi : uitvindingsoctrooi.

  
titel. : Neurobiotoop capsulen, zijnde een mineraal-plantaardig dagsedativum en hypnoticum behorend tot de niet-barbituraat hypnotica.

  
 <EMI ID=1.1> 
- extractum crataegi 25 mg 
- extractum passiflorae 25 mg

  
Voor de neurobiotoop forte capsulen dienen de hoeveelheden van de samenstelling'verdubbeld.

  
 <EMI ID=2.1> 

  
biologisch volwaardige organische en anorganische natuurlijke bestanddelen ter zuivering en uitwisseling tegen gedegenereerde lichaamsmoleculen uit het milieu, waardoor het zenuwstelsel in staatgesteld wordt zijn optimaal herstel te bewerken in plaats van een louter symptomatische geneesmiddelentherapie.

  
 <EMI ID=3.1> 

  
Bij de forte capsulen met verdubbelde hoeveelheden zijn, naast de dagsedatieve werking inzonderheid sporerelementen en bijzondere onuitgeputte kleisubstanties belangrijk voor de opbouw.



  DESCRIPTION

  
applicant: Raphael Willaert, pharmacist, residing in Westrozebeke, Ommegang Oost 7.

  
patent: invention patent.

  
title. : Neurobiotope capsules, which are a mineral-vegetable day sedative and hypnotic belonging to the non-barbiturate hypnotics.

  
 <EMI ID = 1.1>
- extractum crataegi 25 mg
- extractum passiflorae 25 mg

  
For the neurobiotope forte capsules, the amounts of the composition should be doubled.

  
 <EMI ID = 2.1>

  
biologically fully-fledged organic and inorganic natural ingredients for purification and exchange against degenerate environmental body molecules, enabling the nervous system to work on its optimal recovery rather than merely symptomatic drug therapy.

  
 <EMI ID = 3.1>

  
With the forte capsules with doubled quantities, in addition to the day-sedative effect, in particular trace elements and special exhausted clay substances are important for the build-up.
BE1/10006A 1980-10-31 1980-10-31 NEUROBIOTOPIC CAPSULES BE885966A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BE1/10006A BE885966A (en) 1980-10-31 1980-10-31 NEUROBIOTOPIC CAPSULES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE885966 1980-10-31
BE1/10006A BE885966A (en) 1980-10-31 1980-10-31 NEUROBIOTOPIC CAPSULES

Publications (1)

Publication Number Publication Date
BE885966A true BE885966A (en) 1981-02-16

Family

ID=25659384

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10006A BE885966A (en) 1980-10-31 1980-10-31 NEUROBIOTOPIC CAPSULES

Country Status (1)

Country Link
BE (1) BE885966A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743721A1 (en) * 1996-01-19 1997-07-25 Innothera Lab Sa Association of magnesium, Crataegus and Eschscholzia extracts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743721A1 (en) * 1996-01-19 1997-07-25 Innothera Lab Sa Association of magnesium, Crataegus and Eschscholzia extracts

Similar Documents

Publication Publication Date Title
BE885966A (en) NEUROBIOTOPIC CAPSULES
ES2176510T3 (en) MINERAL WOOL SUBSTRATE FOR PLANTS.
Shahba et al. Stability assessment of cinnarizine in self-emulsifying drug delivery systems
BE885965A (en) NEUROBIOTOPIC DROPS
Santos et al. Studies on the neuropharmacological effects of Psidium guyanensis and Psidium pohlianum essential oils
BE885975A (en) ENTEROBIOTOPE CAPSULES
KIM Fluid Inclusion Studies Relating to Tungsten-Tin-Copper
Wahyuni et al. Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats
Moon et al. Studies on the anti-inflammatory and analgesic activities of Ohjuksan
BE885976A (en) MUCOBIOTOPIC DROPS OR SYRUP
Tamaki et al. Parviflorene J, a cytotoxic sesquiterpene dimer with a new rearranged skeleton from Curcuma parviflora
Ichikawa et al. Biochemical CO2 fixation by mimicking zinc (II) complex for active site of carbonic anhydrase
Awadallah et al. Characterisation of the Nile water quality in the zone from Aswan to Giza
Chang et al. Toxicological Evaluation of Medicinal Plants Used for Herbal Drugs (IV)-Acute Toxicity and Antitumor Activities
Belge et al. Critical Review of Bhavana Processes with special reference to its Utility in Ayurvedic Pharmaceutics
BE885967A (en) METABOLOBIOTOPE DROPS
BE885970A (en) HYPERTENSOBIOTOPE DROPS
Ma et al. Acute toxicity study on Mud Chrysanthemum indicum in mice
Lee et al. The inhibitory effects of Houttuynia cordata Thunb against cadmium induced cytotoxicity (II)
BE885972A (en) METABOLOBIOTOPE CAPSULES
Thirumathal et al. Physico- Chemical Studies of Amaravathy Reservoir, Coimbatore District, Tamil Nadu
Sogaard Captopril's beneficial effects on postinfarction myocardial ischemia
Jung et al. Coumarins from the roots of Angelica decursiva-albiflora
Passaperuma et al. Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer.
Cohen et al. Salvage of hibernating myocardium after coronary angioplasty